Status:
UNKNOWN
Impact of Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on Arrhythmias
Lead Sponsor:
Xijing Hospital
Conditions:
Hypertrophic Cardiomyopathy
Arrhythmia
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to learn about the occurrence of various arrhythmias ( tachyarrhythmia and bradyarrhythmia ) during or after Percutaneous Intramyocardial Septal Radiofrequency ...
Eligibility Criteria
Inclusion
- Subject with symptoms that limit daily activities (New York Heart Association functional class \>II, exercise-induced syncope) despite adequate medical treatment or when medical treatment is not tolerated
- Subject with a peak LVOT gradient≥50 mm Hg
- Subject volunteers for the Liwen procedure and received the procedure at the Hypertrophic Cardiomyopathy Center of Xijing Hospital.
Exclusion
- Subject with a peak instantaneous Doppler LVOT gradient of \<50 mm Hg
- Subject with an indication for septal reduction therapy and other lesions requiring surgical intervention (e.g., mitral valve repair/replacement and papillary muscle intervention)
- Subject has end-stage heart failure
Key Trial Info
Start Date :
August 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06031519
Start Date
August 22 2023
End Date
August 31 2024
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ultrasound Medicine Department of Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China, 710032